(Q34635506)

3 August 2017

1 reference

title

Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity (English)

1 reference

3 August 2017

0 references

Giampiero Muccioli

1

0 references

Matthias Tschöp

series ordinal

2

object named as

Matthias Tschöp

1 reference

3 August 2017

3

Mauro Papotti

1 reference

3 August 2017

6

Ezio Ghigo

1 reference

3 August 2017

4

Romano Deghenghi

1 reference

3 August 2017

Mark Heiman

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

European Journal of Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

440

1 reference

3 August 2017

issue

2-3

1 reference

3 August 2017

page(s)

235-254

1 reference

Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Cardiac effects of hexarelin in hypopituitary adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone secretagogues and hypothalamic networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Identification and characterization of a new growth hormone-releasing peptide receptor in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone-releasing peptide (GHRP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Unnatural growth hormone-releasing peptide begets natural ghrelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone-releasing peptides and their analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth Hormone Secretagogues: Physiological Role and Clinical Utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Identification, Characterization, and Biological Activity of Specific Receptors for Natural (Ghrelin) and Synthetic Growth Hormone Secretagogues and Analogs in Human Breast Carcinomas and Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin acts in the central nervous system to stimulate gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Electrical Stimulation of the Rat Periventricular Nucleus Influences the Activity of Hypothalamic Arcuate Neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Central actions of peptide and non-peptide growth hormone secretagogues in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express Fos protein following systemic injection of GH-releasing peptide-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Gastrectomy and osteomalacia: an association not to be forgotten

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Anatomic basis of leptin action in the hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin and motilin: two sides of one coin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Fuel partitioning and food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Role of hypothalamic neuropeptide Y in feeding and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Orally active growth hormone secretagogues: state of the art and clinical perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone secretagogues as corticotrophin-releasing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Endocrine and non-endocrine activities of growth hormone secretagogues in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Biologic activities of growth hormone secretagogues in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Gender and gonadal influences on ghrelin mRNA levels in rat stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin in domestic animals: distribution in stomach and its possible role

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Bone mineral metabolism after total gastrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

A receptor in pituitary and hypothalamus that functions in growth hormone release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin: an orexigenic and somatotrophic signal from the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Bullfrog ghrelin is modified by n-octanoic acid at its third threonine residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Substantial production of ghrelin by a human medullary thyroid carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Immune enhancing effect of a growth hormone secretagogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Presence of ghrelin in normal and adenomatous human pituitary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Effects of growth hormone on bone and muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Central melanocortins and the regulation of weight during acute and chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin stimulates gastric acid secretion and motility in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement of paraventricular nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Neurons with access to the general circulation in the central nervous system of the rat: A retrograde tracing study with fluoro-gold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Kidney produces a novel acylated peptide, ghrelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

A role for ghrelin in the central regulation of feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Binding sites for growth hormone-releasing peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin-induced growth hormone secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Central nervous system control of food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Peptidomimetic regulation of growth hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Adenosine: A partial agonist of the growth hormone secretagogue receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Growth hormone secretagogue receptor family members and ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Obesity and the regulation of energy balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Effects of growth hormone and its secretagogues on bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin Strongly Stimulates Growth Hormone Release in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

A review of postgastrectomy bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin induces adiposity in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Post-prandial decrease of circulating human ghrelin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Circulating ghrelin levels are decreased in human obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Actions of leptin on growth hormone secretagogue-responsive neurones in the rat hypothalamic arcuate nucleus recorded in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

RAPID COMMUNICATIONS: Mutations in the Preproghrelin/Ghrelin Gene Associated with Obesity in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Alterations of circadian rhythmicity and sleep in aging: endocrine consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

GH inhibition of lipogenesis and stimulation of lipolysis in sheep adipose tissue: involvement of protein serine phosphorylation and dephosphorylation and phospholipase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Expression of Ghrelin and of the GH Secretagogue Receptor by Pancreatic Islet Cells and Related Endocrine Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Ghrelin causes hyperphagia and obesity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901432-2

10.1016/S0014-2999(02)01432-2

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference